Related Experiment Video
Updated: Mar 27, 2026

Protocol to Create Chronic Wounds in Diabetic Mice
Published on: September 25, 2019
Superoxide dismutases in chronic gastritis
Dražen Švagelj1,2, Velimir Terzić3, Jasna Dovhanj4
1Department of Pathology and Cytology, General Hospital Vinkovci, Vinkovci, Croatia.
Manganese superoxide dismutase (Mn-SOD) expression increases with chronic inflammation in gastric mucosa. This study found Mn-SOD is more prevalent in moderate to severe gastritis, not in normal gastric tissue.
Area of Science:
- Gastroenterology
- Cellular Biology
- Pathology
Background:
- Superoxide dismutase (SOD) isoforms show altered activity and expression in human gastric diseases.
- Manganese superoxide dismutase (Mn-SOD) is a key antioxidant enzyme in cellular defense against reactive oxygen species.
Purpose of the Study:
- To detect manganese superoxide dismutase (Mn-SOD) activity and expression in gastric mucosa.
- To evaluate the connection between Mn-SOD expression and pathohistological diagnosis, specifically in chronic Helicobacter pylori-negative gastritis.
Main Methods:
- Examined 51 outpatients with upper gastrointestinal symptoms undergoing endoscopy.
- Classified patients into three groups based on histopathological examination of chronic gastritis (absent, moderate, severe inflammation).
- Determined Mn-SOD expression using immunohistochemistry with anti-Mn-SOD antibodies on gastric tissue samples.
Main Results:
- Mn-SOD expression was significantly more frequent in gastric mucosa with moderate and severe inflammation compared to normal mucosa.
- Positive Mn-SOD immunoreactivity was absent in patients with normal histological findings.
- Changes in Mn-SOD expression correlate with the intensity of chronic inflammatory infiltrates in the gastric lamina propria.
Conclusions:
- Mn-SOD expression is altered in chronic gastritis, increasing with inflammation severity.
- Mn-SOD may play a role in the gastric mucosa's response to chronic inflammation.
- Findings highlight Mn-SOD's association with pathohistological changes in gastric mucosa.
More Related Videos
08:57Simultaneous Measurement of Superoxide/Hydrogen Peroxide and NADH Production by Flavin-containing Mitochondrial Dehydrogenases
Published on: February 24, 2018
03:48Author Spotlight: Exploring the Mysteries of Sichuan's Herbal Medicine in Chinese Medicine Research
Published on: March 1, 2024
Related Concept Videos
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...